Afala

N/A

Report date: 2022/01/14 13:23:58
First In Class

Base Information

Drug NameAfala
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProstate-specific antigen modulators
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatitisProstatic Neoplasms
Global Approved IndicationsProstatitisProstatic Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2014/01/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProstatitisProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XC
Related LinksN/A